Sander Slootweg

Chairman at

NorthSea Therapeutics BV

Health Technology

Consumer Services

Finance

Profile

Sander Slootweg is currently Chairman at NorthSea Therapeutics BV, Director at Xention Ltd., Oxyrane Belgium NV, and Azafaros BV, and Managing Partner at Forbion Capital Partners Management Holding BV since 2006.
Former positions include Director roles at Pulmagen Therapeutics (Synergy) Ltd., Abiomed Europe GmbH, Fovea Pharmaceuticals SA, Argenta Ltd., uniQure NV, Pieris Pharmaceuticals, Inc., Alantos Pharmaceuticals, Inc., Forbion European Acquisition Corp., Replimune Group, Inc., and NewAmsterdam Pharma Holding BV (2020–2022), as well as Investment Director at ABN Amro Capital Life Sciences and Non-Executive Director at NewAmsterdam Pharma Co. NV.
Education includes an undergraduate degree from Nyenrode Business Universiteit (1989) and a graduate degree from Vrije Universiteit Amsterdam (1992).

Sander Slootweg active positions

Companies	Position	Start
NorthSea Therapeutics BV NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases	Chairman	-
Azafaros BV Azafaros BV Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for the treatment of rare metabolic disorders	Director/Board Member	-
Xention Ltd. Xention Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs	Director/Board Member	-
Oxyrane Belgium NV	Director/Board Member	-
Forbion Capital Partners Management Holding BV Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor.	Private Equity Investor	01/12/2006

All active positions of Sander Slootweg

Former positions of Sander Slootweg

Companies	Position	End
FRAZIER LIFESCIENCES ACQUISITION CORPORATION	Chairman	-
ENGE HLDGNPV	Director/Board Member	01/11/2023
NewAmsterdam Pharma Holding BV NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Engages in research and development of transformative therapies for cardio metabolic diseases	Director/Board Member	01/11/2022
Argenta Ltd. Argenta Ltd. Pharmaceuticals: MajorHealth Technology Operates as an animal health contract research, development and manufacturing organization	Director/Board Member	01/01/2010
░░░░░ ░░░░░░░░░░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░

See the detail of Sander Slootweg's experience

Training of Sander Slootweg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sander Slootweg's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	19
Nyenrode Business Universiteit Nyenrode Business Universiteit Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Pulmagen Therapeutics (Synergy) Ltd. Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapeutics for respiratory diseases	Commercial Services
ABIOMED Europe GmbH ABIOMED Europe GmbH Medical SpecialtiesHealth Technology Manufactures and markets micro blood pumps	Health Technology
Vrije Universiteit Amsterdam Vrije Universiteit Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Fovea Pharmaceuticals SA Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of ocular diseases	Health Technology
Forbion Capital Partners Management Holding BV Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor.	Finance
ABN Amro Capital Life Sciences
Argenta Ltd. Argenta Ltd. Pharmaceuticals: MajorHealth Technology Operates as an animal health contract research, development and manufacturing organization	Health Technology
Xention Ltd. Xention Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs	Health Technology
uniQure NV uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products	Health Technology
Pieris Pharmaceuticals, Inc. Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology	Health Technology
Replimune Group, Inc. Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies	Health Technology
NorthSea Therapeutics BV NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases	Health Technology
Oxyrane Belgium NV
Azafaros BV Azafaros BV Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for the treatment of rare metabolic disorders	Health Technology
NewAmsterdam Pharma Holding BV NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Engages in research and development of transformative therapies for cardio metabolic diseases	Health Technology
Alantos Pharmaceuticals, Inc.
Forbion European Acquisition Corp. Forbion European Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company	Finance
NewAmsterdam Pharma Co. NV NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases	Health Technology